163 related articles for article (PubMed ID: 36676710)
1. Glypican-3 Differentiates Intraductal Carcinoma and Paget's Disease from Other Types of Breast Cancer.
Alshammari FO; Satari AO; Aljabali AS; Al-Mahdy YS; Alabdallat YJ; Al-Sarayra YM; Alkhojah MA; Alwardat ARM; Haddad M; Al-Sarayreh SA; Al-Saraireh YM
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676710
[No Abstract] [Full Text] [Related]
2. Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients.
Grillo PK; Győrffy B; Götte M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1937-1955. PubMed ID: 33742285
[TBL] [Abstract][Full Text] [Related]
3. Expression profile and prognostic value of glypican-3 in post-operative South Korean hepatocellular carcinoma patients.
Jeon Y; Kim H; Jang ES; Hong S; Kim JW; Yoon YS; Cho JY; Han HS; Jeong SH
APMIS; 2016 Mar; 124(3):208-15. PubMed ID: 26764243
[TBL] [Abstract][Full Text] [Related]
4. Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation.
Wang YL; Zhu ZJ; Teng DH; Yao Z; Gao W; Shen ZY
World J Gastroenterol; 2012 May; 18(19):2408-14. PubMed ID: 22654434
[TBL] [Abstract][Full Text] [Related]
5. Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database.
Moek KL; Fehrmann RSN; van der Vegt B; de Vries EGE; de Groot DJA
Am J Pathol; 2018 Sep; 188(9):1973-1981. PubMed ID: 29935166
[TBL] [Abstract][Full Text] [Related]
6. High glypican-3 expression characterizes a distinct subset of ovarian clear cell carcinomas in Canadian patients: an opportunity for targeted therapy.
Wiedemeyer K; Köbel M; Koelkebeck H; Xiao Z; Vashisht K
Hum Pathol; 2020 Apr; 98():56-63. PubMed ID: 32017945
[TBL] [Abstract][Full Text] [Related]
7. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
8. Glypican-3 is a potential prognostic biomarker for hepatocellular carcinoma after curative resection.
Fu SJ; Qi CY; Xiao WK; Li SQ; Peng BG; Liang LJ
Surgery; 2013 Sep; 154(3):536-44. PubMed ID: 23601901
[TBL] [Abstract][Full Text] [Related]
9. Expression of glypican 3 in placental site trophoblastic tumor.
Ou-Yang RJ; Hui P; Yang XJ; Zynger DL
Diagn Pathol; 2010 Sep; 5():64. PubMed ID: 20868507
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Value of Isolated and Combined MCM3 and Glypican-3 Expression in Hepatocellular Carcinoma: A Novel Immunosubtyping Prognostic Model.
Mohamed AS; Abd El Hafez A; Eltantawy A; Mahfouz M
Appl Immunohistochem Mol Morphol; 2022 Nov-Dec 01; 30(10):694-702. PubMed ID: 36350065
[TBL] [Abstract][Full Text] [Related]
11. CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
Feng J; Zhu R; Chang C; Yu L; Cao F; Zhu G; Chen F; Xia H; Lv F; Zhang S; Sun L
PLoS One; 2016; 11(3):e0151501. PubMed ID: 26977595
[TBL] [Abstract][Full Text] [Related]
12. Local recurrence of mammary Paget's disease after nipple-sparing mastectomy and implant breast reconstruction: a case report and literature review.
Pu Q; Zhao Q; Gao D
World J Surg Oncol; 2022 Sep; 20(1):285. PubMed ID: 36064544
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of glypican 3 in thyroid cancer.
Yamanaka K; Ito Y; Okuyama N; Noda K; Matsumoto H; Yoshida H; Miyauchi A; Capurro M; Filmus J; Miyoshi E
Oncology; 2007; 73(5-6):389-94. PubMed ID: 18511877
[TBL] [Abstract][Full Text] [Related]
14. Glypican-3: a new target for cancer immunotherapy.
Ho M; Kim H
Eur J Cancer; 2011 Feb; 47(3):333-8. PubMed ID: 21112773
[TBL] [Abstract][Full Text] [Related]
15. Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients.
Ning S; Bin C; Na H; Peng S; Yi D; Xiang-hua Y; Fang-yin Z; Da-yong Z; Rong-cheng L
Mol Biol Rep; 2012 Jan; 39(1):351-7. PubMed ID: 21655958
[TBL] [Abstract][Full Text] [Related]
16. Expression of Glypican 3 in low and high grade urothelial carcinomas.
Aydin O; Yildiz L; Baris S; Dundar C; Karagoz F
Diagn Pathol; 2015 Apr; 10():34. PubMed ID: 25896897
[TBL] [Abstract][Full Text] [Related]
17. Reevaluation of glypican-3 as a prognostic marker in HCC using X-tile software.
Pan C; Wang X; Chen W; Tao C; Xu X; Jin L; Chen Y; Zhu L; Zhou L; Pan Z
Med Oncol; 2015 Jan; 32(1):359. PubMed ID: 25432695
[TBL] [Abstract][Full Text] [Related]
18. Glypican-1 Overexpression in Different Types of Breast Cancers.
Alshammari FOFO; Al-Saraireh YM; Youssef AMM; Al-Sarayra YM; Alrawashdeh HM
Onco Targets Ther; 2021; 14():4309-4318. PubMed ID: 34366675
[TBL] [Abstract][Full Text] [Related]
19. Expression of Cox-2 and Bcl-2 in Paget's disease of the breast.
Alikanoglu AS; Yildirim M; Suren D; Tutus B; Kaya V; Topal CS; Keser S; Karadayi AN; Kapucuoglu FN; Ayva S; Gunduz S
Asian Pac J Cancer Prev; 2015; 16(3):1041-5. PubMed ID: 25735328
[TBL] [Abstract][Full Text] [Related]
20. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies].
Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B
Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
